PODNL1 and cancer: The mutant landscape of PODNL1 in pan-cancer showed that PODNL1 altered mainly by amplification and mutation in OV, uterine corpus endometrial carcinoma (UCEC) and lymphoid neoplasm diffuse large B-cell lymphoma (DLBC) at a high level with a surprising alteration rate of more than 4%, especially in OV at the highest alteration rate of 11.47% (Figure 10A).